News Daily News Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis Michael O'Riordan November 22, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2022 Shelley Wood October 03, 2022
News Conference News TCT 2022 RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion Todd Neale September 21, 2022
News Conference News TCT 2022 Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL Yael L. Maxwell September 19, 2022
Presentation TCT 2022 Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) Presenter: Sanjit Jolly September 18, 2022
Presentation TCT 2022 TCT 632: Intravascular Ultrasound-Guided Multivessel Percutaneous Coronary Intervention for Anterior STEMI Complicated by Cardiogenic Shock in a Patient With Cabrol Graft Presenter: Agastya Belur September 17, 2022
Presentation TCT 2022 TCT 682: Ultra-Low Contrast Unprotected Left Main Percutaneous Coronary Intervention Using Intravascular Ultrasound and Sepal Technique Presenter: Bryan Rene Toledano September 17, 2022
News Daily News Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained Yael L. Maxwell July 15, 2022
News Daily News Fewer Women Than Men Get Intracoronary Imaging in PCI, but Why? Caitlin E. Cox June 22, 2022
News Conference News EuroPCR 2022 Distal Radial Access Doesn’t Lower Risk of Occlusion: DISCO RADIAL Michael O'Riordan May 19, 2022
News Daily News Percutaneous Axillary Access: SCAI Calls for Best Practices Caitlin E. Cox April 20, 2022
News Conference News ACC 2022 FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses Michael O'Riordan April 06, 2022
Presentation ACC 2022 Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis: The FLAVOUR Randomized Clinical Trial Presenter: Bon-Kwon Koo April 04, 2022
News Conference News ACC 2022 Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS Michael O'Riordan March 25, 2022